Another Look: Big Pharma & the Opioids
It’s possible something similar is happening today, perhaps not with an opioid but with some other class of drug. Maybe we simply aren’t aware of it yet.
Select Page
by C. Scott McMillin | May 9, 2022 | Addictive Substances | 0 |
It’s possible something similar is happening today, perhaps not with an opioid but with some other class of drug. Maybe we simply aren’t aware of it yet.
by C. Scott McMillin | Apr 14, 2022 | Addictive Substances | 0 |
by C. Scott McMillin | Mar 31, 2022 | Treatment | 0 |
by C. Scott McMillin | Feb 7, 2022 | In the News | 0 |
by C. Scott McMillin | Dec 13, 2021 | Addictive Substances | 0 |
by C. Scott McMillin | Oct 28, 2021 | Addictive Substances | 0 |
by C. Scott McMillin | Oct 25, 2021 | In the News | 0 |
…they’ll argue that since the doctors wrote the prescriptions, there’s no way the pharmacists could be expected to refuse them.
Read Moreby C. Scott McMillin | Sep 6, 2021 | In the News | 0 |
Now this really sounds like what we heard from Purdue Pharma in the early days of the Oxycontin epidemic.
Read Moreby C. Scott McMillin | Jun 3, 2021 | Addiction Clinicians | 0 |
I’ve heard from various physicians over the years that as patient visits grow ever briefer– down to 11 minutes in some clinical settings– doctors are increasingly quick with the prescription pad.
Read Moreby C. Scott McMillin | Mar 29, 2021 | Public Policy | 0 |
It’s the opposite of transparency, and greatly limits opportunities to improve the system, so as to reduce the risk of future boondoggles.
Read Moreby C. Scott McMillin | Nov 16, 2020 | In the News | 0 |
In my experience, those folks at Corporate track everything that affects their revenue and profit margins.
Read Moreby C. Scott McMillin | Oct 19, 2020 | In the News | 0 |
(fines) are unlikely to be paid in the near term as the criminal fine and civil penalty are expected to be considered alongside other claims in Purdue’s bankruptcy proceedings and the company lacks necessary funds to fully repay all creditors…
Read Moreby C. Scott McMillin | Oct 15, 2020 | Addictive Substances, Public Policy | 0 |
For a long time, many medical professionals were resistant to the idea that benzos could be hazardous unless the patient took too many at once, or mixed them with alcohol.
Read Moreby C. Scott McMillin | Sep 7, 2020 | In the News | 0 |
It’s clear Purdue execs knew far more about the dangers of Oxycontin than they were willing to acknowledge. They may simply have lied about it…
Read Moreby C. Scott McMillin | Aug 3, 2020 | In the News | 0 |
The juxtaposition of the two accounts – raw devastation to a family on one hand, and on the other, superrich individuals with high-paid legal talent celebrating after pulling a fast one on the “system” – paints things in a harsher light.
Read Moreby C. Scott McMillin | Mar 5, 2020 | Bookshelf | 0 |
In fact, in many instances, the trauma that occurs after they’re addicted is more damaging than what happened before.
Read Moreby C. Scott McMillin | Feb 27, 2020 | Prevention | 0 |
“The pharmacy’s practice of providing three-month supplies may inadvertently lead more patients to attempt suicide by overdosing…”
Read Moreby C. Scott McMillin | Feb 17, 2020 | Public Policy | 0 |
…the FDA, like the CDC, is just one part of the massive Department of Health and Human Services, and therefore subject to all sorts of political influence and frankly, pressure.
Read More